NRX Pharmaceuticals, Inc. Warrant Share Price
NRXPWNRX Pharmaceuticals, Inc. Warrant Stock Performance
Open $0.15 | Prev. Close $0.14 | Circuit Range N/A |
Day Range $0.15 - $0.15 | Year Range $0.04 - $0.50 | Volume 100 |
Average Traded $0.15 |
NRX Pharmaceuticals, Inc. Warrant Share Price Chart
About NRX Pharmaceuticals, Inc. Warrant
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
NRX Pharmaceuticals, Inc. Warrant Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
23-Oct-25 | $0.15 | $0.15 | +7.14% |
21-Oct-25 | $0.14 | $0.14 | +180.00% |
17-Sep-25 | $0.05 | $0.05 | -32.43% |
28-Aug-25 | $0.08 | $0.07 | -17.78% |
11-Jul-25 | $0.09 | $0.09 | -7.22% |
10-Jul-25 | $0.10 | $0.10 | -3.00% |
09-Jul-25 | $0.09 | $0.10 | +0.00% |